Ken Dominski
About Ken Dominski
Ken Dominski is the Executive Director, Lead, Worldwide Oncology & Hematology Communications at Bristol Myers Squibb, with over 15 years of experience in corporate and agency roles within the healthcare and biopharmaceutical industries.
Title at Bristol Myers Squibb
Ken Dominski currently serves as the Executive Director, Lead, Worldwide Oncology & Hematology Communications at Bristol Myers Squibb. In this role, he is responsible for overseeing global communications strategy within the oncology and hematology sectors.
Career at Bristol Myers Squibb
Ken Dominski has had a long and varied career at Bristol Myers Squibb, holding multiple director-level positions. From 2018 to 2019, he was the Director, EMAC & Intercon Corporate Affairs. Prior to that, he served as the Director, Corporate Communications & Media, from 2013 to 2018, as well as Director, Global/US Diabetes Brand Communications from 2012 to 2013. Earlier, he was the Director, Global/US Immunoscience Brand + Corporate Communications for a one-year term from 2011 to 2012. Ken also held roles as Director, Global/US Diabetes Brand Communications from 2008 to 2011 and Associate Director, Global/US Cardiovascular+Virology Brand Communications from 2006 to 2008.
Previous Experience at Edelman Worldwide
Before joining Bristol Myers Squibb, Ken Dominski worked at Edelman Worldwide as an Account Supervisor in Healthcare from 2003 to 2006. In this role, he was based in New York, NY, and gained valuable experience in the healthcare communications sector.
Educational Background
Ken Dominski holds a Master's degree from the S.I. Newhouse School of Public Communications at Syracuse University. He also earned a Bachelor of Arts from Rutgers University. Additionally, he studied at the Arthur W. Page Society from 2021 to 2022.
Industry Expertise
With over 15 years of experience in corporate and agency roles, Ken Dominski has focused on globally recognized brands in the consumer healthcare and biopharmaceutical industries. He possesses deep knowledge of global pharma, biotech, and healthcare business and is experienced in all aspects of product and corporate communications. His expertise includes media relations, social platforms, issues management, brand awareness, patient education, business development, and financial communications.